{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T13:59:06Z","timestamp":1761919146987},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.dld.2008.07.314","type":"journal-article","created":{"date-parts":[[2008,9,17]],"date-time":"2008-09-17T12:06:49Z","timestamp":1221653209000},"page":"194-200","source":"Crossref","is-referenced-by-count":25,"title":["6-Thioguanine therapy in Crohn\u2032s disease\u2014Observational data in Swedish patients"],"prefix":"10.1016","volume":"41","author":[{"given":"S.H.C.","family":"Almer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Hjortswang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Hindorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.dld.2008.07.314_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00054725-200108000-00001","article-title":"An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapy","volume":"7","author":"Dubinsky","year":"2001","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"10.1016\/j.dld.2008.07.314_bib2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1046\/j.1365-2036.2003.01683.x","article-title":"Tioguanine in patients with Crohn's disease intolerant or resistant to azathioprine\/mercaptopurine","volume":"18","author":"Bonaz","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.dld.2008.07.314_bib3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00042737-200301000-00011","article-title":"6-Thioguanine seems promising in azathioprine- or 6-mercaptopurine-intolerant inflammatory bowel disease patients: a short-term safety assessment","volume":"15","author":"Derijks","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.dld.2008.07.314_bib4","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/j.1572-0241.2003.07413.x","article-title":"Thioguanine: a potential alternate thiopurine for IBD patients allergic to 6-mercaptopurine or azathioprine","volume":"98","author":"Dubinsky","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.dld.2008.07.314_bib5","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1046\/j.1365-2036.2003.01440.x","article-title":"6-thioguanine\u2014efficacy and safety in chronic active Crohn's disease","volume":"17","author":"Herrlinger","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.dld.2008.07.314_bib6","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1080\/00365520510023369","article-title":"A prospective, open-label trial of 6-thioguanine in patients with ulcerative or indeterminate colitis","volume":"40","author":"Teml","year":"2005","journal-title":"Scand J Gastroenterol"},{"issue":"35","key":"10.1016\/j.dld.2008.07.314_bib7","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.3748\/wjg.v11.i35.5540","article-title":"On tolerability and safety of a maintenance treatment with 6-thioguanine in azathioprine or 6-mercaptopurine intolerant IBD patients","volume":"11","author":"de Boer","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2008.07.314_bib8","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1080\/00365520600825166","article-title":"Efficacy and safety of 6-thioguanine in the management of inflammatory bowel disease","volume":"42","author":"Qasim","year":"2007","journal-title":"Scand J Gastroenterol"},{"issue":"6","key":"10.1016\/j.dld.2008.07.314_bib9","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/gut.49.6.874a","article-title":"Why measure thiopurine methyltransferase activity? Direct administration of 6-thioguanine might be the alternative for 6-mercaptopurine or azathioprine","volume":"49","author":"de Jong","year":"2001","journal-title":"Gut"},{"issue":"1, 2","key":"10.1016\/j.dld.2008.07.314_bib10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1046\/j.1445-5994.2003.00321.x","article-title":"6-thioguanine: a new old drug to procure remission in inflammatory bowel disease","volume":"33","author":"Cheung","year":"2003","journal-title":"Int Med J"},{"key":"10.1016\/j.dld.2008.07.314_bib11","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/j.1365-2036.2004.01947.x","article-title":"Thioguanine-nucleotides do not predict efficacy of tioguanine in Crohn's disease","volume":"19","author":"Herrlinger","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2008.07.314_bib12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/01.ftd.0000179839.71138.6d","article-title":"Pharmacokinetics of 6-thioguanine in patients with inflammatory bowel disease","volume":"28","author":"Derijks","year":"2006","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.dld.2008.07.314_bib13","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0016-5085(03)00938-7","article-title":"6-thioguanine can cause serious liver injury in inflammatory bowel disease patients","volume":"125","author":"Dubinsky","year":"2003","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.dld.2008.07.314_bib14","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1097\/01.pas.0000128665.12063.97","article-title":"Early hepatic nodular hyperplasia and submicroscopic fibrosis associated with 6-thioguanine therapy in inflammatory bowel disease","volume":"28","author":"Geller","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.dld.2008.07.314_bib15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.5858\/2004-128-49-ENHOTL","article-title":"Early nodular hyperplasia of the liver occurring with inflammatory bowel diseases in association with thioguanine therapy","volume":"128","author":"Shastri","year":"2004","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"10.1016\/j.dld.2008.07.314_bib16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jhep.2005.02.051","article-title":"A multicenter assessment of liver toxicity by MRI and biopsy in IBD patients on 6-thioguanine","volume":"43","author":"Seiderer","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2008.07.314_bib17","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.dld.2007.10.013","article-title":"Absence of nodular regenerative hyperplasia after low-dose 6-thioguanine maintenance therapy in inflammatory bowel disease patients","volume":"40","author":"de Boer","year":"2008","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2008.07.314_bib18","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1111\/j.1572-0241.2007.01530.x","article-title":"6-thioguanine associated nodular regenerative hyperplasia in patients with inflammatory bowel disease may induce portal hypertension","volume":"102","author":"Ferlitsch","year":"2007","journal-title":"Am J Gastroenerol"},{"key":"10.1016\/j.dld.2008.07.314_bib19","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/ibd.20323","article-title":"Variceal hemorrhage in a patient with ulcerative colitis treated with 6-thioguanine","volume":"14","author":"Fritz","year":"2008","journal-title":"Infl Bowel Dis"},{"key":"10.1016\/j.dld.2008.07.314_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000091662","article-title":"6-Thioguanine (6-TG) treatment in inflammatory bowel disease: a critical appraisal by an European 6-TG working party","volume":"73","author":"de Boer","year":"2006","journal-title":"Digestion"},{"key":"10.1016\/j.dld.2008.07.314_bib21","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(80)92767-1","article-title":"A simple index of Crohn's disease activity","volume":"1","author":"Harvey","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2008.07.314_bib22","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/00007691-200206000-00005","article-title":"Differences between children and adults in thiopurine methyltransferase activity and metabolite formation during thiopurine therapy: possible role of concomitant methotrexate","volume":"24","author":"Pettersson","year":"2002","journal-title":"Ther Drug Monit"},{"issue":"2","key":"10.1016\/j.dld.2008.07.314_bib23","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1373\/clinchem.2003.023846","article-title":"Pyrosequencing of TPMT alleles in a general Swedish population and in patients with inflammatory bowel disease","volume":"50","author":"Haglund","year":"2004","journal-title":"Clin Chem"},{"key":"10.1016\/j.dld.2008.07.314_bib24","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.dld.2006.10.007","article-title":"Toxicity of 6-thioguanine: no hepatotoxicity in a series of IBD-patients treated with long-term, low dose 6-thioguanine. Some evidence for dose or metabolite level dependent effects?","volume":"39","author":"Gilissen","year":"2007","journal-title":"Dig Liver Dis"},{"issue":"2","key":"10.1016\/j.dld.2008.07.314_bib25","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2036.2006.02977.x","article-title":"Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease","volume":"24","author":"Hindorf","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.dld.2008.07.314_bib26","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1046\/j.1365-2036.2000.00872.x","article-title":"The use of 6-mercaptopurine in patients with inflammatory bowel disease after failure of azathioprine therapy","volume":"14","author":"Boulton-Jones","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.dld.2008.07.314_bib27","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1023\/A:1005569808947","article-title":"Use of 6-mercaptopurine in patients with inflammatory bowel disease previously intolerant of azathioprine","volume":"45","author":"Bowen","year":"2000","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.dld.2008.07.314_bib28","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/00365520410009492","article-title":"6-mercaptopurine in patients with inflammatory bowel disease and previous digestive intolerance of azathioprine","volume":"40","author":"Domenech","year":"2005","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2008.07.314_bib29","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00508-007-0841-0","article-title":"A systematic survey evaluating 6-thioguanine-related hepatotoxicity in patients with inflammatory bowel disease","volume":"119","author":"Teml","year":"2007","journal-title":"Wien Klin Wochenschr"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865808005975?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865808005975?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T17:02:27Z","timestamp":1631811747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865808005975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S1590865808005975"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2008.07.314","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}